Coping strategies, anxiety and depression related to the COVID-19 pandemic in lung transplant candidates and recipients. Results from a monocenter series.
Anxiety
COVID-19
Coping strategy
Depression
Lung transplantation
Journal
Respiratory medicine and research
ISSN: 2590-0412
Titre abrégé: Respir Med Res
Pays: France
ID NLM: 101746324
Informations de publication
Date de publication:
Nov 2021
Nov 2021
Historique:
received:
01
03
2021
revised:
17
05
2021
accepted:
21
06
2021
pubmed:
10
8
2021
medline:
15
12
2021
entrez:
9
8
2021
Statut:
ppublish
Résumé
The COVID-19 pandemic has been associated with an increase in anxiety and depression symptoms in people. We investigated the impact of the pandemic on coping strategies and anxiety and depression in lung transplantation (LT) recipients and patients with end-stage chronic lung disease awaiting LT. We retrospectively investigated coping strategies by using the Coping Inventory for Stressful Situations questionnaire and anxiety and depression symptoms by the Hospital Anxiety and Depression scale in 115 LT candidates and recipients. Overall, 63 participants (20 women; median age 59 years [interquartile range 52•65]) answered one or both questionnaires (49 LT recipients and 14 LT candidates). The preferred coping strategy was task-focused for 51 (86.4%) participants, with no difference between LT recipients and candidates nor according to the main anamnestic and clinical data. Eleven patients had suspected or proven depression symptoms, and 18 had suspected or proven anxiety symptoms. Coping strategies related to COVID-19 did not differ by presence of anxiety or depression symptoms. In the current pandemic, healthcare professionals should consider these results to provide relevant psychological help to these fragile populations and promote a systematic and wide multidisciplinary assessment of LT recipients and candidates.
Sections du résumé
BACKGROUND
BACKGROUND
The COVID-19 pandemic has been associated with an increase in anxiety and depression symptoms in people. We investigated the impact of the pandemic on coping strategies and anxiety and depression in lung transplantation (LT) recipients and patients with end-stage chronic lung disease awaiting LT.
METHODS
METHODS
We retrospectively investigated coping strategies by using the Coping Inventory for Stressful Situations questionnaire and anxiety and depression symptoms by the Hospital Anxiety and Depression scale in 115 LT candidates and recipients.
RESULTS
RESULTS
Overall, 63 participants (20 women; median age 59 years [interquartile range 52•65]) answered one or both questionnaires (49 LT recipients and 14 LT candidates). The preferred coping strategy was task-focused for 51 (86.4%) participants, with no difference between LT recipients and candidates nor according to the main anamnestic and clinical data. Eleven patients had suspected or proven depression symptoms, and 18 had suspected or proven anxiety symptoms. Coping strategies related to COVID-19 did not differ by presence of anxiety or depression symptoms.
CONCLUSION
CONCLUSIONS
In the current pandemic, healthcare professionals should consider these results to provide relevant psychological help to these fragile populations and promote a systematic and wide multidisciplinary assessment of LT recipients and candidates.
Identifiants
pubmed: 34371237
pii: S2590-0412(21)00036-2
doi: 10.1016/j.resmer.2021.100847
pmc: PMC8260501
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
100847Informations de copyright
Copyright © 2021 SPLF and Elsevier Masson SAS. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest CG received speaker fees and travel support from Pfizer, MSD; fees for board memberships from SOS Oxygène and Pulmatrix; grant support from Ohre Pharma, Pfizer, MSD, SOS Oxygène, ISIS Medical, and AstraZeneca. HM reports grants from Pfizer, and fees from Novartis, and Boehringer. JM received congress reimbursement fees from CSLBehring and Fisher&Paykel.
Références
Clin Microbiol Infect. 2020 Jun;26(6):669-672
pubmed: 32278082
BMJ. 1988 Dec 10;297(6662):1544
pubmed: 3147074
Prim Care Companion J Clin Psychiatry. 2010;12(2):
pubmed: 20694116
Respir Med Res. 2021 May;79:100808
pubmed: 33422721
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
J Pers Soc Psychol. 1984 Apr;46(4):839-52
pubmed: 6737195
Gen Hosp Psychiatry. 2016 Jul-Aug;41:1-5
pubmed: 27302717
Psychiatr Serv. 2007 Jun;58(6):836-43
pubmed: 17535945
Rech Soins Infirm. 2001 Dec;(67):68-83
pubmed: 21374910
J Pers Soc Psychol. 1990 May;58(5):844-54
pubmed: 2348372
Transplantation. 2021 Jan 1;105(1):177-186
pubmed: 33141808
Respir Med Res. 2020 Nov;78:100758
pubmed: 32474398
Expert Rev Respir Med. 2021 Jan;15(1):5-7
pubmed: 32578464
J Pers Assess. 1998 Dec;71(3):349-67
pubmed: 9933941
J Cyst Fibros. 2020 Nov;19(6):880-887
pubmed: 32768311
Singapore Med J. 2020 Jul;61(7):350-356
pubmed: 32241071
Gen Hosp Psychiatry. 2012 Mar-Apr;34(2):127-38
pubmed: 22245165
Int J Geriatr Psychiatry. 2000 Dec;15(12):1090-6
pubmed: 11180464
Psychosomatics. 2016 May-Jun;57(3):238-45
pubmed: 26927623
Ann Thorac Surg. 2021 Oct;112(4):1142-1149
pubmed: 33171173